440 likes | 751 Views
Imaging of cirrhosis. Valérie Vilgrain Service de Radiologie Hôpital Beaujon France. Cirrhosis. Extensive fibrosis and regenerative nodules Main causes alcohol ingestion chronic hepatitis C chronic hepatitis B hemochromatosis Wilson disease Micronodular nodules < 3 mm
E N D
Imaging of cirrhosis Valérie Vilgrain Service de Radiologie Hôpital Beaujon France
Cirrhosis • Extensive fibrosis • and regenerative nodules • Main causes alcohol ingestion • chronic hepatitis C • chronic hepatitis B • hemochromatosis • Wilson disease • Micronodular nodules < 3 mm • Macronodular larger nodules
Diagnosis • Liver diseases mimicking cirrhosis • Prognosis • Non invasive diagnosis of fibrosis
Diagnosis of cirrhosis Nodularity of the liver surface Nodular internal architecture Changes of hepatic morphology Vascular changes Portal hypertension
Nodularity of the liver surfaceNodular internal architecture Correlate with the gross appearance of cirrhosis Surface . Initially described with high frequency transducer . Seen with US, CT and MR Internal architecture . Best seen with US and MR . Regenerative nodules hypoechoic - hypointense . Septa hyperechoic - hyperintense Dilelio, Radiology 1989
CirrhosisSurface nodularity • Se Sp Accuracy • Di Lelio 88 94 89 • Richard 58 86 81 • Ferral 88 82 84 • Ladenheim 13 88 76 • Colli 54 95 Radiology 1989 J. Radiol 1985 Gastrointest 1992 Radiology 1992 Radiology 2003
Hepatic morphologic changesQuantitative results (1) • Caudate lobe • Caudate-right lobe ratio (> 0.65) • Modified caudate-right lobe ratio (> 0.90) Harbin, Radiology 1980 Awaya, Radiology 2002
Hepatic morphologic changesQuantitative results (2) • Segment 4 • Control group 43 ± 8 mm • Cirrhosis 28 ± 9 mm • Cutoff: 30 mm • Limit: measurement obtained at US Lafortune, Radiology 1998
Hepatic morphologic changesOther signs • Expanded gallbladder fossa • Specificity and PPV of 98% • Associated with atrophy of the segment 4 • Enlargment of hilar periportal space • Seen in 98% in early cirrhosis • Cutoff of 10 mm • . Control group: 5.3 mm • . Cirrhosis: 15.5 mm Ito, Radiology 1999 Ito, JMRI 2000
Vascular changes Hepatic veins Normally triphasic Cirrhosis decreased diameter altered waveform in 50% correlated with the severity reduced transit time (contrast US) Bolondi, Radiology 1991 Colli, AJR 1994 Albrecht, Lancet 1999
Vascular changes Hepatic artery HA diastolic velocity > PV velocity Increased HA diameter Increased RI and PI of the hepatic artery Portal vein velocity Liver vascular index = -------------------------- Hepatic artery PI < 12 cm/sec Iwao, Am J Gastroenterol 1997
Portal hypertension • Increased pressure > 15 mm Hg • Portocaval gradient > 5 mm Hg • Portal hemodynamics • Collaterals • Ascites • Splenomegaly
Diagnosis of PHTSplanchnic veins • Enlargment of splanchnic veins • Lack of caliber variations of SMV • Reversed flow SMV 2.1% • splenic vein 3.1% Alpern, Radiology 1987 Bolondi, Radiology 1982
Diagnosis of PHT • Diameter of the portal vein > 13 mm Se 40% • > 15 mm Se 12.5% • Alterations of portal blood flow abs of end-diastolic • arterialized flow • bidirectional flow • reversed flow 1% Bolondi, Radiology 1982 Vilgrain, Gastrointest Radiol 1990 Lafortune 1990 Gaiani, Gastroenterology 1991
Diagnosis of PHTLeft gastric vein • Diameter > 6 mm 26% • Hepatofugal flow 78% Wachsberg, AJR 1994
Diagnosis of PHTOther collaterals • Retroperitoneal veins • Omental veins • Rectal varices • Gallbladder varices
Diagnosis of PHT • Mean portal velocity Mean portal blood flow • cm/sec ml/min • controls cirrhosis controls cirrhosis • Gaiani et al 19 2.1 11.4 3.7 919 285 1197 625 • Moriyasu et al 15.3 4 9.7 2.6 899 284 870 289 • Zoli et al 16 0.5 10.5 0.6 694 23 736 46 • Ohnishi et al 17 3.9 12 3 648 186 690 258 Gaiani, Hepatology 1989 Moriyasu, AJR 1986 Zoli, J Ultrasound Med 1985 Ohnishi, Gastroenterology 1985
CirrhosisUltrasound-Score • Accuracy • Surface nodularity • + mean portal velocity 82% • Spleen length 84% • + mean portal velocity • Spleen length 89% • +mean portal velocity • +hepatic venous spectrum Gaiani, J Hepatol 1997 Aubé, J Hepatol 1999 Aubé, Eur J Gastroentrol 2004
Liver diseases mimicking cirrhosis Common findings Morphologic changes of the liver May give signs of PHT Generally vascular or biliary diseases But Rarely cause nodularity of the liver surface Rarely have nodular regeneration
Primary sclerosing cholangitis • Lobular contour 73% • Caudate hypertrophy 98% • Lateral segment atrophy 58% • Posterior segment atrophy 36% • Dilated ducts 67% • End stage disease Dodd, Radiology 1999
Congenital hepatic fibrosis • Mean age 39 years • Liver morphologic abnormalities 89% • Splenomegaly 83% • Varices 78% • Renal abnormalities 56% • Ductal plate malformation 50% Zeitoun, Radiology 2004
Congenital hepatic fibrosis • Hypertrophy of the left lateral • Normal or hypertrophy of the segment 4 • Atrophy of the right lobe Zeitoun, Radiology 2004
Budd-Chiari disease • Hypertrophy of the caudate lobe > 50% • Lobar atrophy/hypertrophy • Abnormal hepatic veins • Hepatic venous collaterals
Portal cavernoma Central vs peripheral zone Vilgrain, Radiology 2006
Imaging in assessing prognosis? • Comparison between compensated and uncompensated cirrhosis • Serial imaging • Stability and functional reserve • . Hypertrophy and increasing of the caudate lobe 1, 2, 3 • . High caudate to right lobe ratio 1 • . Increasing lateral segment 2 • Clinical progression • . Progressive atrophy of the right lobe and medial segment 2 • . Spleen enlargment 3 • . Varices3 1. Watanabe, Dig Dis Sci 1999 2. Ito, Radiology 1998 3. Ito, AJR 1997
Limitations of non invasive imaging • Most signs seen in advanced cirrhosis • No specific signs associated with fibrosis • => Need to find other criteria • other imaging
Diagnosis of fibrosis • Blood tests: Fibrotest • Elastrography • Liver MR diffusion • Liver perfusion
Fibrotest • Alpha 2 macroglobulin • Haptoglobin • Apolipoprotein 1 • Total bilirubin • GGT • ALT • 0 - 0.10 Probability of fibrosis < 10% • 0.10 - 0.60 Liver biopsy recommended • 0.60 - 1.00 Probability of fibrosis > 90% Imbert-Bismuth, Lancet 2001
Elastography (Fibroscan) • Ultrasound (5MHz) and low frequency • (50 Hz) elastic waves • Propagation velocity is related to elasticity
Liver MR diffusion • Reduced ADC in cirrhosis Taouli, Radiology 2003
Liver perfusion Van Beers, AJR 2001
CONCLUSION • Today, non invasive imaging is crucial for diagnosing cirrhosis and its complications. • Tomorrow, the challenge of imaging will be to detect early stages of fibrosis and cirrhosis and to demonstrate therapeutic response.